Eli Lilly’s combination antibody therapy for COVID-19 cuts risk of hospitalization and death by 87%
Eli Lilly & Co says its combination antibody therapy is effective at treating mild to moderate cases of COVID-19. The treatment, ...
Read moreEli Lilly & Co says its combination antibody therapy is effective at treating mild to moderate cases of COVID-19. The treatment, ...
Read moreEli Lilly's chief financial officer Josh Smiley (above) has resigned following a probe into his 'personal relationship with an employee' ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline